CHIA-YU CHU2019-12-042019-12-0420050007-0963https://www.scopus.com/inward/record.uri?eid=2-s2.0-14844336821&doi=10.1111%2fj.1365-2133.2005.06404.x&partnerID=40&md5=e5025a77046555f0c3bd3f1a7e0f9bdehttps://scholars.lib.ntu.edu.tw/handle/123456789/434996[SDGs]SDG3corticosteroid; fexofenadine; metronidazole; mometasone furoate; pimecrolimus; adult; aged; case report; cream; disease exacerbation; drug use; female; general condition improvement; human; letter; maintenance therapy; perioral dermatitis; priority journal; pruritus; recurrent disease; remission; rosacea; seborrheic dermatitis; telangiectasia; Adrenal Cortex Hormones; Adult; Aged; Dermatologic Agents; Drug Eruptions; Facial Dermatoses; Female; Humans; Male; Rosacea; TacrolimusThe use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea [21]letter10.1111/j.1365-2133.2005.06404.x157276762-s2.0-14844336821